Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York

National Institutes of Health Clinical Center, Bethesda

University of Maryland/Greenebaum Cancer Center, Baltimore

Emory University Hospital/Winship Cancer Institute, Atlanta

Ohio State University Comprehensive Cancer Center, Columbus

Case Western Reserve University, Cleveland

Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland

Cleveland Clinic Foundation, Cleveland

M D Anderson Cancer Center, Houston

UCSF Medical Center-Parnassus, San Francisco

Dana-Farber Cancer Institute, Boston